Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACLX |
---|---|---|
09:32 ET | 1677 | 52.165 |
09:39 ET | 100 | 51.52 |
09:41 ET | 200 | 51.56 |
09:45 ET | 800 | 51.43 |
09:48 ET | 300 | 51.24 |
09:50 ET | 100 | 51.22 |
09:54 ET | 1100 | 51.22 |
09:56 ET | 100 | 51.18 |
09:57 ET | 300 | 51.13 |
10:01 ET | 2417 | 51.53 |
10:06 ET | 500 | 51.71 |
10:08 ET | 610 | 51.75 |
10:10 ET | 385 | 51.735 |
10:14 ET | 100 | 51.595 |
10:15 ET | 200 | 51.615 |
10:17 ET | 200 | 51.615 |
10:19 ET | 1020 | 51.91 |
10:21 ET | 100 | 51.91 |
10:24 ET | 400 | 51.99 |
10:26 ET | 700 | 52.275 |
10:28 ET | 100 | 52.22 |
10:32 ET | 200 | 52.245 |
10:33 ET | 329 | 52.285 |
10:35 ET | 300 | 52.385 |
10:37 ET | 2630 | 52.3675 |
10:39 ET | 1100 | 52.695 |
10:42 ET | 700 | 52.735 |
10:44 ET | 800 | 52.425 |
10:48 ET | 3185 | 52.48 |
10:50 ET | 1000 | 52.335 |
10:51 ET | 2919 | 52.42 |
10:53 ET | 100 | 52.42 |
10:55 ET | 100 | 52.26 |
10:57 ET | 100 | 51.96 |
11:00 ET | 100 | 51.98 |
11:02 ET | 803 | 52.09 |
11:04 ET | 100 | 52.105 |
11:09 ET | 1998 | 52.23 |
11:11 ET | 1401 | 52.235 |
11:13 ET | 400 | 52.28 |
11:15 ET | 100 | 52.35 |
11:20 ET | 500 | 52.3625 |
11:22 ET | 100 | 52.36 |
11:24 ET | 100 | 52.375 |
11:26 ET | 770 | 52.58 |
11:27 ET | 500 | 52.68 |
11:29 ET | 500 | 52.49 |
11:31 ET | 600 | 52.44 |
11:33 ET | 100 | 52.565 |
11:40 ET | 200 | 52.59 |
11:42 ET | 2488 | 52.58 |
11:44 ET | 100 | 52.65 |
11:49 ET | 566 | 52.655 |
11:54 ET | 200 | 52.65 |
11:56 ET | 200 | 52.72 |
11:58 ET | 100 | 52.68 |
12:02 ET | 300 | 52.63 |
12:03 ET | 300 | 52.5725 |
12:05 ET | 1200 | 52.54 |
12:07 ET | 300 | 52.48 |
12:09 ET | 1366 | 52.56 |
12:12 ET | 200 | 52.555 |
12:16 ET | 200 | 52.54 |
12:18 ET | 100 | 52.545 |
12:20 ET | 400 | 52.555 |
12:23 ET | 1665 | 52.9 |
12:27 ET | 922 | 52.775 |
12:32 ET | 830 | 52.755 |
12:34 ET | 300 | 52.75 |
12:38 ET | 100 | 52.76 |
12:39 ET | 300 | 52.86 |
12:41 ET | 100 | 52.835 |
12:43 ET | 100 | 52.84 |
12:45 ET | 800 | 52.935 |
12:48 ET | 1200 | 52.79 |
12:50 ET | 600 | 52.74 |
12:52 ET | 300 | 52.76 |
12:54 ET | 300 | 52.76 |
12:56 ET | 2072 | 52.83 |
12:57 ET | 200 | 52.775 |
12:59 ET | 300 | 52.64 |
01:01 ET | 500 | 52.53 |
01:03 ET | 100 | 52.51 |
01:10 ET | 800 | 52.645 |
01:12 ET | 825 | 52.72 |
01:15 ET | 1702 | 52.725 |
01:17 ET | 810 | 52.9 |
01:21 ET | 3040 | 53.17 |
01:24 ET | 1045 | 52.81 |
01:26 ET | 200 | 52.84 |
01:28 ET | 500 | 52.82 |
01:30 ET | 200 | 52.855 |
01:33 ET | 476 | 52.86 |
01:35 ET | 400 | 52.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcellx Inc | 2.8B | -50.8x | --- |
IDEAYA Biosciences Inc | 2.8B | -19.7x | --- |
Janux Therapeutics Inc | 2.8B | -37.9x | --- |
Arvinas Inc | 2.3B | -4.7x | --- |
Xenon Pharmaceuticals Inc | 2.9B | -14.1x | --- |
Rhythm Pharmaceuticals Inc | 2.2B | -8.6x | --- |
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -50.8x |
Price/Sales (TTM) | 21.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.